IUHSA
FATE icon

Itau Unibanco Holding S.A.’s Fate Therapeutics FATE Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-226
Closed -$1.29K – 549
2023
Q1 		$1.29K Hold
226
– – ﹤0.01% 496
2022
Q4 		$2.28K Sell
226
-19
-8% -$357 ﹤0.01% 499
2022
Q3 		$5K Hold
245
– – ﹤0.01% 518
2022
Q2 		$6K Sell
245
-50
-17% -$1.38K ﹤0.01% 440
2022
Q1 		$11K Buy
295
+12
+4% +$465 ﹤0.01% 424
2021
Q4 		$17K Buy
283
+4
+1% +$227 ﹤0.01% 373
2021
Q3 		$17K Buy
279
+8
+3% +$628 ﹤0.01% 344
2021
Q2 		$24K Buy
+271
New +$21.8K ﹤0.01% 273

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Itau Unibanco Holding S.A.'s FATE Position: Q2 2023 in Review

Itau Unibanco Holding S.A. sold out of Fate Therapeutics (FATE) in Q2 2023, closing a stake of 226 shares — an estimated $1.29K sold.

Itau Unibanco Holding S.A. first reported a position in FATE in Q2 2021 and held it in 8 quarters. The position peaked at $24K in Q2 2021. 188 funds tracked by Wall St. Rank hold FATE as of Q2 2023.

  • Itau Unibanco Holding S.A. reported no remaining Fate Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 226 Fate Therapeutics shares in Q2 2023, an estimated $1.29K.
  • Itau Unibanco Holding S.A. first reported a position in Fate Therapeutics in Q2 2021 and held it in 8 quarters.
  • Itau Unibanco Holding S.A.'s Fate Therapeutics position peaked at $24K in Q2 2021.
  • 188 funds tracked by Wall St. Rank held Fate Therapeutics as of Q2 2023.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q2 2023, filed 14 Aug 2023.